A young patient is brought into the emergency department having suffered a traumatic brain injury. Hypothermia may be considered as part of the treatment regimen. If so, how soon after the injury should treatment begin, and how long should treatment last? Dr. Jamie Hutchison, associate professor of critical care medicine and pediatrics at the University of Toronto, and research director of critical care medicine at the Hospital for Sick Children in Toronto, explains the mechanism used for cooling and examines potential links between data on hypothermia treatment for adults and similar therapy for children. Dr. Mark Nolan Hill hosts.
Hypothermic Treatment for Children With TBI
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
A young patient is brought into the emergency department having suffered a traumatic brain injury. Hypothermia may be considered as part of the treatment regimen. If so, how soon after the injury should treatment begin, and how long should treatment last? Dr. Jamie Hutchison, associate professor of critical care medicine and pediatrics at the University of Toronto, and research director of critical care medicine at the Hospital for Sick Children in Toronto, explains the mechanism used for cooling and examines potential links between data on hypothermia treatment for adults and similar therapy for children. Dr. Mark Nolan Hill hosts.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
IgG4-RD Case Conversations: IgG4-related Autoimmune Pancreatitis and Cholangitis
Updates From the 7th World Symposium Task Force
Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies
Chemotherapy Strategies for Metastatic PDAC
A Practical Guide to Prescribing in HF
Clinical Conundrums in ARIA: Nuances of Microhemorrhages when Evaluating an MRI for ARIA
Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies
The Importance of PD-L1 Testing: Shaping the Future of Treatment in ESCC
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?